Page 92 - Quest Diagnostics News Today

/PRNewswire/ -- The "Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, Drug Type, End Users/Setting Type, Region), Regulatory Status,...

Girard Partners LTD. lessened its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 18.2% during the 1st quarter, Holdings Channel reports. The firm owned 20,550 shares of the medical research company’s stock after selling 4,557 shares during the quarter. Girard Partners LTD.’s holdings in Quest Diagnostics were worth $2,907,000 at the end of […]

Girard Partners LTD. lessened its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 18.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,550 shares of the medical research company’s stock after selling 4,557 shares during […]

Quest Diagnostics, a provider of diagnostic information services, has announced that its AAVrh74 ELISA assay (CDx) has been granted breakthrough device designation from the U.S. Food and Drug Administration (FDA).

When Pinnock was drafted by the Jets in 2021, it was a dream he never dared to imagine coming true, because it was too perfect.

To accelerate business insights, a clinical lab turns to a data fabric - SiliconANGLE

/PRNewswire/ -- The "Alport Syndrome Treatment Market Share, Size, Trends, Industry Analysis Report, By Product Type, By Disease Type, By Route Of...

With every fact sheet download, Cleveland Diagnostics will make a donation to the nonprofit Zero Prostate Cancer to fund research and support initiatives.

Cancer diagnostic market is segmented by test, technology, application, end user and product. Based on the test, the cancer diagnostics market is segmented...

Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing: Global Markets and Technologies" report has been added to ...